SLNO
Soleno Therapeutics Inc (SLNO)
Healthcare • NASDAQ • $52.950.00%
- Symbol
- SLNO
- Exchange
- NASDAQ
- Sector
- Healthcare
- Industry
- Biotechnology
- Price
- $52.95
- Daily Change
- 0.00%
- Market Cap
- $2.76B
- Trailing P/E
- 27.44
- Forward P/E
- -23.33
- 52W High
- $90.32
- 52W Low
- $29.43
- Analyst Target
- $53.00
- Dividend Yield
- N/A
- Beta
- -2.22
Soleno Therapeutics, Inc., biopharmaceutical company, focuses on the development and commercialization of novel therapeutics for the treatment of rare diseases. Its lead product candidate is VYKAT XR, an extended-release tablets for the treatment of Prader-Willi Syndrome. The company was formerly known as Capnia, Inc. and changed its name to Soleno Therapeutics, Inc. in May 2017. Soleno Therapeutics, Inc. was incorporated in 1999 and is headquartered in Redwood City, California.
Company websiteResearch SLNO on Stk-Ai
Stk-Ai gives you screening across 100+ fundamental metrics, AI-powered analysis, target predictions, backtested signals, and portfolio tracking — all in one place.
Data shown is for informational purposes only and is not investment advice. Prices and metrics may be delayed.